MRGPRX2 and atopic eczema: Furthermore, MRGPRX2 has recently been implicated in the pathogenesis of mastocytosis (11), neurogenic inflammation (12), chronic urticaria (13), chronic prurigo (8), rosacea (14, 15), atopic dermatitis (16), and allergic contact dermatitis/itch (17).